Keytruda, Avastin, Lixiana get reimbursement in Scotland; Exchange plans limit access to HIV meds;

@FiercePharma: #ICYMI yesterday: U.S. judge orders Valeant, Ackman to face insider trading suit. Story | Follow @FiercePharma

@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce

@CarlyHFierce: U.S. judge orders Valeant, Ackman to face insider trading suit. Article | Follow @CarlyHFierce

> The Scottish Medicines Consortium gave its thumbs up to Merck & Co.'s ($MRK) cancer immunotherapy Keytruda in melanoma, Roche's ($RHHBY) Avastin for ovarian cancer, and Daiichi Sankyo's blood thinner Lixiana. Report

> The Trans-Pacific Partnership could limit the availability of affordable medicines, World Health Organization chief Margaret Chan said Thursday. Report

> Despite long-standing recommendations to screen patients using antipsychotics for diabetes annually, only 30% receive the tests, a study found. Report

> Some Affordable Care Act exchange plans have limited the number of HIV drugs covered or charge higher out-of-pocket costs for them, a new analysis found. Report

> Chinese regulators stiff-armed 11 new drug applications because of inadequate data in a quality-oriented crackdown. Report

Medical Device News

@FierceMedDev: AliveCor adds former Google exec as CEO to further consumer ECG push. Story | Follow @FierceMedDev

@VarunSaxena2: Boston Sci's Watchman hit by restrictive CMS coverage decision, recall over blood leakage. Article | Follow @VarunSaxena2

@EmilyWFierce: Women are suing Endo Health Solutions and Patheon for child support after contraceptive packaging mishap. More | Follow @EmilyWFierce

> Resurgent 23andMe CEO says the genetic testing company is not up for sale. Article

> Philips to launch pneumonia Dx wearable to prevent child deaths in poorer countries. News

Biotech News

@FierceBiotech: China's new pharma crackdown may help top companies. Story | Follow @FierceBiotech

@JohnCFierce: Gilead, Sanofi singled out as worst offenders in failing to disclose trial data. More | Follow @JohnCFierce

@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." News | Follow @DamianFierce

> Biogen's risky Alzheimer's odyssey raises prospects for new biotech deals. Story

> Portola rolls toward approval for its 'breakthrough' anticoagulant antidote. More

CRO News

> Quintiles lends its data-crunching know-how to Apple's ResearchKit. More

> PPD deepens its Japanese focus with new joint venture leadership. Story

> WuXi and Lilly pair up to develop a cardio drug in China. Article

> CRO BioDuro merges with Formex after a private equity takeout. More

> Quintiles founder stepping down as chairman after 33 years. News

Pharma Manufacturing News

> Endo, Patheon sued over unplanned pregnancies tied to contraceptive mishap. Item

> CMO Formex and CRO BioDuro merge operations. More

> Cellular Biomedicine adds facility in China that will help with CAR-T processing. Story

> AmerisourceBergen says quality will be PharMEDium's distinguisher, but acknowledges 'quick diligence' ahead of deal. Report

> Pharma cargo thefts jump with $558,000 average losses reported. News

Pharma Asia News

> India's drug regulator handcuffed by low funding, lack of trained personnel. Story

> Japan's Astellas Pharma gets $727M for ailing dermatology unit as it swings to new areas. More

> WuXi and Eli Lilly in pact on cardio candidate development in China. Article

> Japanese ministry knocks Novartis unit, again, on side effects nondisclosure. News

> Daiichi loses Supreme Court decision on Apotex generic. More

And Finally... Pfizer's ($PFE) vitamin C supplement Emergen-C was among a list of supplement brands called out by CBC for failing to live up to their labels. Report